126 related articles for article (PubMed ID: 4054071)
21. Studies on the activation mechanism of fibrinolytic enzyme system in plasma by human pancreatic elastase.
Toki N; Takasugi S; Ishizu K; Sato H; Sumi H
Thromb Haemost; 1982 Feb; 47(1):8-13. PubMed ID: 6176043
[TBL] [Abstract][Full Text] [Related]
22. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of urokinase on lipopolysaccharide-induced disseminated intravascular coagulation in rats: focus on organ function and endothelin levels.
Asakura H; Asamura R; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Yoshida T; Miyamoto K; Nakao S
Thromb Haemost; 2005 Apr; 93(4):724-8. PubMed ID: 15841319
[TBL] [Abstract][Full Text] [Related]
24. Coagulation and fibrinolysis in rats poisoned with mercuric chloride.
Michalska M; Mirowski M; Wierzbicki R
Pol J Pharmacol Pharm; 1988; 40(4):365-71. PubMed ID: 3146750
[TBL] [Abstract][Full Text] [Related]
25. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
26. Immobilization of plasminogen activator, urokinase, on nylon.
Sugitachi A; Takagi K; Imaoka S; Kosaki G
Thromb Haemost; 1978 Apr; 39(2):426-36. PubMed ID: 580991
[TBL] [Abstract][Full Text] [Related]
27. Urokinase quality: analysis of different preparations.
Rogatti W; Yokoigawa K; Kobayashi T
Thromb Haemost; 1985 Apr; 53(2):245-8. PubMed ID: 4024035
[TBL] [Abstract][Full Text] [Related]
28. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.
Korninger C; Collen D
Thromb Haemost; 1981 Aug; 46(2):561-5. PubMed ID: 6795744
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
van Giezen JJ; Boon GI; Jansen JW; Bouma BN
Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
[TBL] [Abstract][Full Text] [Related]
30. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
31. The transport of 125I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators.
Sasaki K; Moriyama S; Tanaka Y; Sumi H; Toki N; Robbins KC
Blood; 1985 Jul; 66(1):69-75. PubMed ID: 4039958
[TBL] [Abstract][Full Text] [Related]
32. [Fibrinolytic activity of acyl-urokinase].
Stürzebecher J; Kroneck I; Klöcking HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
Ieko M
Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
de Munk GA; Groeneveld E; Rijken DC
Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
[TBL] [Abstract][Full Text] [Related]
35. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
36. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
37. [Thrombolytic effect of urokinase upon various methods of administration into the body].
Andreenko GV; Serebriakova TN; Podorol'skaia LV; Afanasenko GA; Liaginskiĭ AV; Raevskaia AK
Vopr Med Khim; 1992; 38(1):44-6. PubMed ID: 1441294
[TBL] [Abstract][Full Text] [Related]
38. Effects of a "single shot" of urokinase on fibrinolytic activities in patients with IgA nephropathy.
Tomino Y; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y; Sakai H; Itoh K; Ikeda N
Tokai J Exp Clin Med; 1984 Mar; 9(1):43-7. PubMed ID: 6535301
[TBL] [Abstract][Full Text] [Related]
39. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
[TBL] [Abstract][Full Text] [Related]
40. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
